Treace Medical Concepts (TMCI)
NASDAQ:TMCI
Want to see TMCI full AI Analyst Report?
Total Valuation
Treace Medical Concepts has a market cap or net worth of $260.14M. The enterprise value is $264.15M.
Market Cap$260.14M
Enterprise Value$264.15M
Share Statistics
Treace Medical Concepts has 64,872,980 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding64,872,980
Owned by Insiders28.33%
Owned by Institutions20.48%
Financial Efficiency
Treace Medical Concepts’s return on equity (ROE) is -0.68 and return on invested capital (ROIC) is -33.86%.
Return on Equity (ROE)-0.68
Return on Assets (ROA)-0.31
Return on Invested Capital (ROIC)-33.86%
Return on Capital Employed (ROCE)-0.34
Revenue Per Employee492.34K
Profits Per Employee-136.58K
Employee Count432
Asset Turnover1.12
Inventory Turnover1.19
Valuation Ratios
The current PE Ratio of Treace Medical Concepts is ―. Treace Medical Concepts’s PEG ratio is -0.79.
PE Ratio―
PS Ratio0.73
PB Ratio1.77
Price to Fair Value1.77
Price to FCF-5.26
Price to Operating Cash Flow-22.42
PEG Ratio-0.79
Income Statement
In the last 12 months, Treace Medical Concepts had revenue of 212.69M and earned -59.00M in profits. Earnings per share was -0.93.
Revenue212.69M
Gross Profit169.75M
Operating Income-54.15M
Pretax Income-59.00M
Net Income-59.00M
EBITDA-43.18M
Earnings Per Share (EPS)-0.93
Cash Flow
In the last 12 months, operating cash flow was -12.93M and capital expenditures -13.04M, giving a free cash flow of -25.97M billion.
Operating Cash Flow-12.93M
Free Cash Flow-25.97M
Free Cash Flow per Share-0.40
Dividends & Yields
Treace Medical Concepts pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.58
52-Week Price Change-24.16%
50-Day Moving Average2.77
200-Day Moving Average3.37
Relative Strength Index (RSI)70.20
Average Volume (3m)918.48K
Important Dates
Treace Medical Concepts upcoming earnings date is Aug 11, 2026, After Close (Confirmed).
Last Earnings DateMay 8, 2026
Next Earnings DateAug 11, 2026
Ex-Dividend Date―
Financial Position
Treace Medical Concepts as a current ratio of 4.31, with Debt / Equity ratio of 17.56%
Current Ratio4.31
Quick Ratio3.13
Debt to Market Cap0.09
Net Debt to EBITDA-0.08
Interest Coverage Ratio-10.18
Taxes
In the past 12 months, Treace Medical Concepts has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Treace Medical Concepts EV to EBITDA ratio is -3.67, with an EV/FCF ratio of -5.37.
EV to Sales0.74
EV to EBITDA-3.67
EV to Free Cash Flow-5.37
EV to Operating Cash Flow-9.91
Balance Sheet
Treace Medical Concepts has $51.85M in cash and marketable securities with $13.55M in debt, giving a net cash position of $38.30M billion.
Cash & Marketable Securities$51.85M
Total Debt$13.55M
Net Cash$38.30M
Net Cash Per Share$0.59
Tangible Book Value Per Share$1.07
Margins
Gross margin is 79.72%, with operating margin of -25.46%, and net profit margin of -27.74%.
Gross Margin79.72%
Operating Margin-25.46%
Pretax Margin-27.74%
Net Profit Margin-27.74%
EBITDA Margin-20.30%
EBIT Margin-25.24%
Analyst Forecast
The average price target for Treace Medical Concepts is $4.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$4.50
Price Target Upside131.96% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast-1.66%
EPS Growth Forecast-12.59%